AFM
RLYB icon

Anson Funds Management’s Rallybio RLYB Stock Holding History

Anson Funds Management’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,996
Closed -$440K – 202
2023
Q4 		$440K Buy
+22,996
New +$562K 0.05% 131

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Anson Funds Management's RLYB Position: Q1 2024 in Review

Anson Funds Management sold out of Rallybio (RLYB) in Q1 2024, closing a stake of 22,996 shares — an estimated $440K sold.

Anson Funds Management first reported a position in RLYB in Q4 2023 and held it in 1 quarter. The position peaked at $440K in Q4 2023. 62 funds tracked by Wall St. Rank hold RLYB as of Q1 2024.

  • Anson Funds Management reported no remaining Rallybio position as of Q1 2024 after selling out during the quarter.
  • Anson Funds Management sold 22,996 Rallybio shares in Q1 2024, an estimated $440K.
  • Anson Funds Management first reported a position in Rallybio in Q4 2023 and held it in 1 quarter.
  • Anson Funds Management's Rallybio position peaked at $440K in Q4 2023.
  • 62 funds tracked by Wall St. Rank held Rallybio as of Q1 2024.

Based on Anson Funds Management's 13F filing for Q1 2024, filed 14 May 2024.